Well Purposed. The commercial case for a healthier world
The fortnightly letter on health systems, economics, and what it actually takes to build and scale in HealthTech - read by 7,500 founders, investors, and operators.
In June, I announced that I had become Chair of Biomarx, a MedTech company developing rapid, automated and affordable liquid-biopsy diagnostics. I promised to write more about what governance maturity looks like at this stage. This is the first of those letters.
A board is not there to be informe...
Yesterday I posted a reference map: ÂŁ8.6bn of UK private health cover, five distinct buyer archetypes, each holding a different budget, committee, and timeline (LaingBuisson, 2026). The response told me what I already suspected: most HealthTech pipelines treat this as one market, rather than the ...
Let's talk about a person who is rarely in the room.
Every significant private market HealthTech commercial conversation has a cast; the occupational health lead who championed the product, the HR director who sponsored the evaluation, the procurement officer who manages the process. These are t...
Â
This is the full version of the LinkedIn series introduced over the last five weeks. The series ran one stage per Monday: Validate, Identify, Target, Articulate, Land.
The VITAL Framework is what I use with the Series A HealthTech founders I advise through Well Purposed. It is the operational c...
This morning's letter went out with a broken link to the Playbook. The link had exactly one job - and fluffed it.
Here it is, The WELL Founder Playbook, working this time:Â https://www.wellpurposed.com/the-WELL-Founder
A practical, founder-first guide to building the personal infrastructure requir...
The most important business decision I made in my third year of scaling Healthy Nibbles was not a strategy decision, or a hiring decision, or even a product decision.
Â
It was the decision to stop making major commercial calls when I was running on four hours of sleep, back-to-back meetings, and ...
When UK HealthTech founders and investors talk about African health systems, the framing is almost always developmental. Africa as a future market. Africa as a place where simpler versions of Western products will eventually find a home. Africa as downstream.
Â
That framing is wrong. And the cost...
There is a meeting happening right now inside the NHS organisation you're trying to sell into.
Â
You are not in it. Your clinical champion is not in it either.
Â
It is the meeting where your product's future gets decided, and the person running it has never heard of you.
Â
THE TWO-ROOM PROBLEM
...
In the last issue we framed The Prevention Economy. This issue goes deeper for founders and builders, helping you frame why healthcare buyers cannot account for what your product prevents, and what to do about it.
The problem no one names
There is a structural problem in how healthcare systems ac...
The prevention argument, on paper, is won.
Â
The evidence is clear: chronic disease is preventable, often reversible if caught early, and exponentially cheaper to address upstream than downstream. The IWBI data I work with shows that built environment interventions alone can reduce cardiovascular...
The thing that Series A celebrates, doing everything yourself, is the same thing that prevents Series B from arriving on schedule.
I've had some version of this conversation four times in the past month. A founder, eighteen months post-close, working harder than they were pre-close. Revenue movin...
Why post-raise health and longevity ventures stall at the moment they appear strongest, and what to do about it.
Most founders expect growth to feel stabilising.
Revenue increases.
The team expands.
Investors lean in.
Partnerships get larger.
On paper, everything looks stronger.
And yet, this i...
Well Purposed. The commercial case for a healthier world
The fortnightly letter on health systems, economics, and what it actually takes to build and scale in HealthTech - read by 7,500 founders, investors, and operators.
 LET'S TALK
Take your first step in going from post-raise pressure to repeatable growth, with a strategy and clarity. Leave your contact details and a brief summary of your priorities and I'll be in touch very soon.
